Skip to main content

Find Clinical Trials

Home
Conditions
NSCLC (Advanced Non-small Cell Lung Cancer)

Clinical trial condition

NSCLC (Advanced Non-small Cell Lung Cancer)

Explore clinical trials studying NSCLC (Advanced Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.

51 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

NSCLC (Advanced Non-small Cell Lung Cancer) trial results

Not Yet Recruiting

PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy

NCT07014215

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function

NCT06823258

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors

NCT06652529

Conditions: Adenoma, Adnexal Diseases, Bronchial Neoplasms, +38 more
Locations: Not specified

View Trial Details

Completed

Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

NCT06613633

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Wuhan Tongji Hospital Wuhan, Hubei, China

Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer

NCT07121387

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Shanghai Pulmonary Hospital Shanghai, China

View Trial Details

Completed

Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer

NCT01211483

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Glendale, Arizona, United States

TRM - Oncology Research Associates, PLLC, d/b/a Pinnacle Oncology Hematology Scottsdale, Arizona, United States

Anaheim, California, United States

Encinitas, California, United States

View all 52 locations

View Trial Details

Active, Not Recruiting

Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC

NCT07703228

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

A Phase II Clinical Trial of Ivonescimab Plus Third-generation EGFR-TKIs in Advanced Non-small Cell Lung Cancer With Gradual or Potential Progression After EGFR-TKIs Treatment

NCT07669051

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shandong cancer hospital and institute Jinan, Shandong, China

View Trial Details

Active, Not Recruiting

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

NCT07491211

Conditions: Brain Diseases, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Neoplasms, +17 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

Wuhan Tongji Hospital Wuhan, Hubei, China

Shanghai Jiao Tong University Affiliated Chest Hospital Shanghai, China

View Trial Details

Active, Not Recruiting

Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer

NCT07262671

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Cancer hospital of Fudan University Shanghai, Shanghai Municipality, China

View Trial Details